Cytokine Drizzle—The Rationale for Abandoning “Cytokine Storm”
- 3 March 2021
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Shock
- Vol. 56 (5), 667-672
- https://doi.org/10.1097/shk.0000000000001769
Abstract
Background: “Cytokine storm” has been used to implicate increased cytokine levels in the pathogenesis of serious clinical conditions. Similarities with SARS CoV-2 and the 2012 Middle Eastern Respiratory Syndrome (MERS) led early investigators to suspect a “cytokine storm” resulting in an unregulated inflammatory response associated with the significant morbidity and mortality induced by SARS CoV-2. The threshold of blood cytokines necessary to qualify as a “cytokine storm” has yet to be defined. Methods: A literature review was conducted to identify cytokine levels released during 11 assorted clinical conditions or diseases. Weighted averages for various cytokines were calculated by multiplying the number of patients in the paper by the average concentration of each cytokine. Correlation between cytokine levels for individual conditions or diseases were assessed using Pearson's correlation coefficient. Results: The literature was reviewed to determine blood levels of cytokines in a wide variety of clinical conditions. These conditions ranged from exercise and autoimmune disease to septic shock and therapy with chimeric antigen receptor T cells (CAR-T). The most frequently measured cytokine was IL-6 which ranged from 24,123 pg/ml in septic shock to 11 pg/ml after exercise. In patients with severe SARS CoV-2 infections, blood levels of IL-6 were only 43 pg/ml, nearly three magnitudes lower than IL-6 levels in patients with septic shock. The clinical presentations of these different diseases do not correlate with blood levels of cytokines. Additionally, there is poor correlation between the concentrations of different cytokines among the different diseases. Specifically, blood levels of IL-6 did not correlate with levels of IL-8, IL-10, or TNF. Septic shock had the highest concentrations of cytokines, yet multiple cytokine inhibitors have failed to demonstrate improved outcomes in multiple clinical trials. Patients with autoimmune diseases have very low blood levels of cytokines (rheumatoid arthritis, IL-6 = 34 pg/ml; Crohn's disease, IL-6 = 5 pg/ml), yet respond dramatically to cytokine inhibitors. Conclusion: The misleading term “cytokine storm” implies increased blood levels of cytokines are responsible for a grave clinical condition. Not all inflammatory conditions resulting in worsened disease states are correlated with significantly elevated cytokine levels, despite an association with the term “cytokine storm”. “Cytokine storm” should be removed from the medical lexicon since it does not reflect the mediators driving the disease nor does it predict which diseases will respond to cytokine inhibitors.Keywords
This publication has 75 references indexed in Scilit:
- Dose-Dependent Effects of Endotoxin on Neurobehavioral Functions in HumansPLOS ONE, 2011
- The Correlation between Increased Serum Concentrations of Interleukin-6 Family Cytokines and Disease Activity in Rheumatoid Arthritis PatientsYonsei Medical Journal, 2011
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman diseaseBlood, 2008
- The Variations in the Immunologic Features and Interleukin-6 Levels for the Surgical Treatment of Cardiac MyxomasSurgery Today, 2007
- Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patientsCritical Care Medicine, 2001
- Recombinant Human Interleukin‐10 Fails to Alter Proinflammatory Cytokine Production or Physiologic Changes Associated with the Jarisch‐Herxheimer ReactionThe Journal of Infectious Diseases, 2000
- Confirmatory interleukin-1 receptor antagonist trial in severe sepsisCritical Care Medicine, 1997
- Sepsis and serum cytokine concentrationsCritical Care Medicine, 1997
- Pentoxifylline Fails to Prevent the Jarisch-Herxheimer Reaction or Associated Cytokine ReleaseThe Journal of Infectious Diseases, 1996
- Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever.The Journal of Experimental Medicine, 1992